Clinical Trials
19 trialsNCT07526675 2026-04-13
Bioblation
Benha University
Phase NA Not yet recruiting
NCT06051942 2026-01-28
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
PROCEPT BioRobotics
Phase NA Active not recruiting
NCT05739071 2025-09-11
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Phase NA Enrolling by invitation
NCT03802851 2025-08-27
HOLEP-RTPC
University of Kansas Medical Center
Phase NA Recruiting
NCT07070687 2025-07-17
Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Management and Quality of Life in Cervical Cancer
Fudan University
Phase NA Completed
NCT05415696 2024-08-09
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Stanford University
Phase NA Withdrawn
NCT04284761 2024-06-24
Biolen-PC
Alessa Therapeutics Inc.
Phase 1 Completed
NCT00866554 2023-06-02
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
CHU de Quebec-Universite Laval
Phase 2 Completed
NCT05851521 2023-05-09
HERMES
Lyx Institute
Phase NA Unknown
NCT03549650 2022-03-04
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Terminated
NCT04190641 2021-10-14
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
Ambu A/S
Phase NA Completed
NCT03831321 2019-02-05
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Istanbul Medeniyet University
Phase 4 Unknown
NCT03104907 2018-11-29
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT03701659 2018-10-10
TUPKRP Combined With MAB Therapy for LUTS/PCa
The Third Xiangya Hospital of Central South University
Phase NA Unknown
NCT02492542 2018-03-14
Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy
Peking University People's Hospital
Phase NA Unknown
NCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00410514 2014-04-04
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Astellas Pharma Inc
Phase 2 Completed
NCT00681148 2013-11-21
Botulinum Toxin Injection With Prostate Brachytherapy
Emory University
Phase 2 Withdrawn
NCT01939756 2013-09-11
Baobab
University of Rome Tor Vergata
Phase 1/2 Completed